immunocompromised patients
A Study on the Pattern of Fungal Infections and Clinical Profile in Immunocompromised Patients with Special Reference to Characterisation and Molecular Study of Candida Species In A Tertiary Care Hospital
145
Invasive Fungal Sinusitis in Immunocompromised Patients: A Multicenter, University Hospital Experience in Shiraz
6
EVALUATION OF PSYCHOTIC ILLNESS AND TREATMENT STATUS IN IMMUNOCOMPROMISED PATIENTS
11
Characterization of the Polyproline Region of the Hepatitis E Virus in Immunocompromised Patients
9
Current management of parainfluenza pneumonitis in immunocompromised patients: a review
7
Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
8
RNA Populations in Immunocompromised Patients as Reservoirs for Novel Norovirus Variants
13
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates
8
Utility of bronchoalveolar lavage in the management of immunocompromised patients presenting with lung infiltrates
12
Etiologic Agents of Candidemia in Pediatric Immunocompromised Patients
7
A review for Cryptosporidiosis among Immunocompromised Patients in Iraq
5
Herpes Zoster Induced Osteomyelitis in the Immunocompromised Patients: A 10-year Multicenter Study
5
Borna Disease Virus RNA in Immunocompromised Patients in Southwestern France
5
Impact of early detection of acute invasive fungal rhinosinusitis in immunocompromised patients
6
A Clinico Pathological Study of 300 cases of warts in immunocompetent and immunocompromised patients.
77
Dental implants in immunocompromised patients: a systematic review and meta-analysis
12
Intracranial cryptococcosis in immunocompromised patients: CT and MR findings in 29 cases
7
CT of Central Nervous System Infections in Immunocompromised Patients
5
Oral infections and septicemia in immunocompromised patients with hematologic malignancies
5
Mathematical modeling of HBV with the antiviral therapy for the immunocompromised patients
32